Cargando…

Bogus "M.Ds."

Detalles Bibliográficos
Autor principal:	Karnik, C. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thacker 1929
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5164410/ https://www.ncbi.nlm.nih.gov/pubmed/29009589

Ejemplares similares

Bogus Diplomas
Publicado: (1920)

Bogus Diplomas
Publicado: (1873)

Bogus Diplomas
Publicado: (1891)

Bogus Diplomas
Publicado: (1877)

Bogus Diplomas
Publicado: (1884)

Bogus Allergy Treatment
por: David, T. J.
Publicado: (1987)

The Philadelphia Bogus Diplomas
Publicado: (1881)

The Bogus Diploma Traffic
Publicado: (1881)

Beware of Bogus Dentists
Publicado: (1886)

A Bogus Directory
Publicado: (1884)

Bogus Medical Colleges
Publicado: (1891)

Bogus Medical Journalism
Publicado: (1896)

The Bogus Diploma Business in Pennsylvania
Publicado: (1881)

Bogus Veterinary Medical Degrees
Publicado: (1881)

Foreign Bogus Diploma Mills
Publicado: (1883)

War against Bogus Colleges and Degrees
Publicado: (1899)

Some More Quackery and Bogus Diplomas
Publicado: (1896)

TET2 deficiency promotes MDS-associated leukemogenesis
por: Huang, Feiteng, et al.
Publicado: (2022)

Real or bogus: Predicting susceptibility to phishing with economic experiments
por: Chen, Yan, et al.
Publicado: (2018)

Teledentistry and COVID-19: Be Mindful of Bogus “Good” Ideas!
por: Giraudeau, Nicolas
Publicado: (2021)

Vitamin D: Bolus Is Bogus—A Narrative Review
por: Mazess, Richard B., et al.
Publicado: (2021)

Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC
por: Huber, Sandra, et al.
Publicado: (2023)

ASXL1 frameshift mutations drive inferior outcomes in CMML without negative impact in MDS
por: Sallman, David A, et al.
Publicado: (2017)

New corruption detected: Bogus impact factors compiled by fake organizations
por: Jalalian, Mehrdad, et al.
Publicado: (2013)

The bogus taste test: Validity as a measure of laboratory food intake
por: Robinson, Eric, et al.
Publicado: (2017)

Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?
por: Zeidan, Amer M., et al.
Publicado: (2018)

How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic?
por: Tesfaye, Wubshet, et al.
Publicado: (2020)

William Jarvie, M.D.S.
Publicado: (1922)

SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase
por: Huber, Sandra, et al.
Publicado: (2022)

Vitamin D: A single initial dose is not bogus if followed by an appropriate maintenance intake
por: Wimalawansa, Sunil J., et al.
Publicado: (2022)

Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients
por: Balducci, Estelle, et al.
Publicado: (2022)

Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN
por: Mestrum, Stefan G. C., et al.
Publicado: (2020)

Stewart Bailey Palmer, M.D.S.
Publicado: (1903)

Stewart B. Palmer, M.D.S.
Publicado: (1903)

Reply to: Vitamin D: A single initial dose is not bogus if followed by an appropriate maintenance intake
por: Mazess, Richard B., et al.
Publicado: (2022)

William A. Bronson, M.D., M.D.S.
Publicado: (1890)

W. J. Smyth, M.D.S., L.D.S.
por: Janlusz, H. J.
Publicado: (1903)

A SYSTEMATIC METANALYSIS ON DIAGNOSTIC VALUE OF DsG3 ELISA FOR PEMPHIGUS VULGARIS
por: Wiwanitkit, Viroj
Publicado: (2009)

WTAP–VIRMA counteracts dsDNA binding of the m(6)A writer METTL3–METTL14 complex and maintains N(6)-adenosine methylation activity
por: Yan, Xuhui, et al.
Publicado: (2023)

William C. Barrett, M.D., D.D.S., M.D.S.
Publicado: (1903)

Cannot write session to /tmp/vufind_sessions/sess_750jdtafo5d8ltdmil1t5n64pd